EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-neoplastic activity of celastrol in experimentally-induced mammary adenocarcinoma in mice: targeting wnt/β-catenin signaling pathway

Mohamed M Salama, Randa A Zaghloul, Rania M Khalil, Mamdouh M El-Shishtawy

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04148-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Mohamed M Salama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 35712, Egypt. mohamed.salama@deltauniv.edu.eg. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Triterpenes, Mammary Neoplasms, Experimental, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Delta University for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural bioactive compounds with anti-neoplastic effects, such as celastrol (CLS), have attracted considerable interest in recent years. The present study aimed to investigate the effect of CLS on wnt/β-catenin signaling, and its potential combination with doxorubicin (Dox) to enhance chemotherapeutic effects. After intramuscular inoculation of Ehrlich tumor cells, tumor-bearing mice received CLS (2 mg/kg , i.p), Dox (5 mg/kg, once/week, i.p), and their combination for 21 days. Treatment with CLS showed showing antioxidant and anti-inflammatory, as evidenced by a significant increase in glutathione content and a significant decrease in the malondialdehyde, interleukin 6, and interleukin 1β concentrations. CLS also inhibited VEGF-mediated angiogenesis. The current study revealed that CLS downregulated β‐catenin gene expression with subsequent downstream target genes, such as cyclin-D1 , and survivin , which dampens tumor cell proliferation and triggers cell cycle arrest as well as induces apoptosis as indicated by the increased expression of p53, caspase‐3. The current study concludes that CLS exerted its anti-neoplastic activity by suppressing the wnt/β-catenin signaling pathway, and opens a new perspective for combining CLS with Dox to enhance its chemotherapeutic effects and reduce the oxidative imbalance and inflammatory responses associated with Dox treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wnt Signaling PathwayTriterpenesMammary Neoplasms, ExperimentalAdenocarcinomaAntineoplastic AgentsAnimalsPentacyclic TriterpenesFemaleDoxorubicinMiceCarcinoma, Ehrlich Tumorbeta CateninApoptosisCell Proliferation

Stichwörter der Autor:innen

CelastrolCyclin-D1DoxorubicinEhrlich solid carcinomaSurvivingβ-catenin

Substanzen

Pentacyclic TriterpenescelastrolTriterpenesDoxorubicinbeta CateninAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 35712, Egypt. mohamed.salama@deltauniv.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. mohamed.salama@deltauniv.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 35712, Egypt.

Förderung

  • Delta University for Science and Technology

Zitieren

APA

Salama, M. M., Zaghloul, R. A., Khalil, R. M., & El-Shishtawy, M. M. (2025). Anti-neoplastic activity of celastrol in experimentally-induced mammary adenocarcinoma in mice: targeting wnt/β-catenin signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04148-1

Vancouver

Salama MM, Zaghloul RA, Khalil RM, El-Shishtawy MM. Anti-neoplastic activity of celastrol in experimentally-induced mammary adenocarcinoma in mice: targeting wnt/β-catenin signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04148-1

BibTeX
@article{Salama2025,
  author = {Salama, Mohamed M and Zaghloul, Randa A and Khalil, Rania M and El-Shishtawy, Mamdouh M},
  title = {Anti-neoplastic activity of celastrol in experimentally-induced mammary adenocarcinoma in mice: targeting wnt/β-catenin signaling pathway},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04148-1}
}
Kostenlos starten →